Literature DB >> 16098902

Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management.

Mitchel S Hoffman1, David Griffin, Stephen Tebes, Richard J Cardosi, Martin A Martino, James V Fiorica, Jorge L Lockhart, Edward C Grendys.   

Abstract

OBJECTIVE: The purpose of this study was to 1) report on the distribution of bowel segments resected in a population of patients who underwent primary optimal cytoreductive surgery for epithelial ovarian cancer, and 2) discuss implications for surgical management regarding resection of these bowel segments. STUDY
DESIGN: This was a retrospective study from 1995 to 2003 of 144 ovarian cancer patients who underwent primary optimal cytoreductive operations that included bowel resection.
RESULTS: Bowel segments removed and major complications are presented in tabulated form. Eighty-one out of 144 resections were rectosigmoid only. Thirty-six percent had extensive involvement of colon segments separate from the rectosigmoid. Excluding hemorrhage, 9 patients (6%) experienced a major complication.
CONCLUSION: The present study does suggest the necessity for a highly individualized approach to the surgical management of epithelial ovarian cancer patients who can be optimally cyto-reduced by resection of multifocal colonic involvement. Further study is needed to better assess the complications, function, and oncologic outcome of the different surgical approaches to these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16098902     DOI: 10.1016/j.ajog.2005.03.046

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  [Peritoneal carcinomatosis in ovarian cancer. Methods and treatment results].

Authors:  J Pfisterer; P Harter; F Hilpert; A du Bois
Journal:  Chirurg       Date:  2007-12       Impact factor: 0.955

Review 2.  En bloc pelvic resection of ovarian cancer with rectosigmoid colectomy: a literature review.

Authors:  Myeong-Seon Kim; Joseph J Noh; Yoo-Young Lee
Journal:  Gland Surg       Date:  2021-03

3.  A Comparison of Thermal Plasma Energy Versus Argon Beam Coagulator-Induced Intestinal Injury After Vaporization in a Porcine Model.

Authors:  Edward J Tanner; Erica Dun; Yukio Sonoda; Alexander B Olawaiye; Dennis S Chi
Journal:  Int J Gynecol Cancer       Date:  2017-01       Impact factor: 3.437

Review 4.  Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer.

Authors:  Jing-Yi Chern; John P Curtin
Journal:  Curr Treat Options Oncol       Date:  2016-01

Review 5.  Extrapelvic bowel resection and anastomosis in cytoreductive surgery for ovarian cancer.

Authors:  Joo-Hyuk Son; Suk-Joon Chang
Journal:  Gland Surg       Date:  2021-03

6.  Subtotal Colectomy as Part of Debulking Surgery for Advanced-stage Ovarian Cancer.

Authors:  Nicolae Bacalbasa; Camelia Diaconu; Laura Iliescu; Simona Dima; Ovidiu Gabriel Bratu; Dragos Cretoiu; Adrian Neacsu; Alexandru Filipescu; Cornel Savu; Irina Balescu
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

7.  Rectosigmoidian Involvement in Advanced-stage Ovarian Cancer - Intraoperative Decisions.

Authors:  Nicolae Bacalbasa; Irina Balescu; Simona Dima
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

8.  Prognostic role of bowel involvement in optimally cytoreduced advanced ovarian cancer: a retrospective study.

Authors:  Giorgio Giorda; Angiolo Gadducci; Emilio Lucia; Roberto Sorio; Valentina E Bounous; Francesco Sopracordevole; Andrea Tinelli; Gustavo Baldassarre; Elio Campagnutta
Journal:  J Ovarian Res       Date:  2014-07-09       Impact factor: 4.234

9.  Protective ostomies in ovarian cancer surgery: a systematic review and meta-analysis.

Authors:  Beatriz Navarro Santana; Esmeralda Garcia Torralba; Jose Verdu Soriano; Maria Laseca; Alicia Martin Martinez
Journal:  J Gynecol Oncol       Date:  2022-03       Impact factor: 4.401

10.  Retroileal colorectal anastomosis after left-sided or transverse colectomy for advanced serous carcinoma of the ovary or uterus.

Authors:  Lea A Moukarzel; Joao Casanova; José Filipe Cunha; Philip B Paty; Emmanouil P Pappou; Elizabeth Jewell; Dennis S Chi
Journal:  Gynecol Oncol Rep       Date:  2021-07-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.